E. K. Malone

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours

Kenneth M. Rassnick, Dennis B. Bailey, David Russell et al. · Veterinary and Comparative Oncology · 2010 · 56 citations

Surgical Oncology, Grade Iii Mcts, Pathology +21

Cross-sectional study to investigate the association between vitamin D status and cutaneous mast cell tumours in Labrador retrievers

Joseph J. Wakshlag, Kenneth M. Rassnick, E. K. Malone et al. · British Journal Of Nutrition · 2011 · 56 citations · Full text

Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogs

Kenneth M. Rassnick, Dennis B. Bailey, E. K. Malone et al. · Veterinary and Comparative Oncology · 2010 · 41 citations

Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours*

E. K. Malone, Kenneth M. Rassnick, Joseph J. Wakshlag et al. · Veterinary and Comparative Oncology · 2010 · 30 citations

Tyrosine Kinase Inhibitor, Tumor Biology, Medicine +13

A prospective evaluation of the impact of second‐opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer

R. C. Regan, Kenneth M. Rassnick, E. K. Malone et al. · Veterinary and Comparative Oncology · 2013 · 14 citations

Diagnostic Agreement, Second-opinion Histopathology, Histopathology Review +16